Delivery Order SPE2DB24D2205-SPE2DB25FDZED

Award Date 3/5/25

Potential Completion Date 3/6/25

Potential Value $17K

Federal Agency

Defense Logistics Agency

Awardee

Amerisourcebergen Drug Corp KABZK8W6PQT3

Ultimate Awardee

Not listed

NAICS Category

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

PSC Category

6505 - Drugs And Biologicals

Federal Contract Vehicle

Not listed

Set-Aside Type

No Set-Aside Used

Extent Competed

Full and Open Competition

Major Defense Program

Not listed

Pricing Type

Firm Fixed Price

Place of Performance

Conshohocken, PA 19428, USA

Solicitation Procedures

Negotiated Proposal / Quote

Number Of Offers Received

Not listed

Legislative Mandate

Not listed

National Interest Action

Not listed

Research Type

Not listed

Primary Consortia Member

Not listed

This contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,176.00 firm fixed-price delivery order is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The contract has a period of performance through March 6, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award was not designated under any set-aside program.

Generated 7/1/25, 2:42 PM